Intravenous Dexamethasone for Ropivacaine Axillary Block

Last updated: January 30, 2018
Sponsor: Centre Hospitalier Universitaire de Besancon
Overall Status: Completed

Phase

3

Condition

Chronic Pain

Post-surgical Pain

Anesthesia

Treatment

N/A

Clinical Study ID

NCT02862327
P/2015/275
  • Ages > 18
  • All Genders

Study Summary

Prospective monocentric double-blind controlled randomised trial Aim is to assess prolonged postsurgical analgesia by intravenous dexamethasone versus intravenous placebo, after ultrasound guided axillary brachial plexus block

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • ASA 1,2 et 3

  • surgery under axillary brachial plexus block

  • aged >18 years

  • signed information consent

Exclusion

Exclusion Criteria:

  • impaired coagulation

  • contraindication to regional anesthesia or technical impossibility

  • opioids or pain killers abuse or addiction

  • steroids consumption in the past 6 months

  • dementia or under administrative supervision

  • delay of surgery to short to allow regional anesthesia

  • pregnancy and breastfeeding

  • allergy and contraindication to dexamethasone or ropivacaine

  • anticipated bad observation of treatment

  • patient enrolled in another trial

Study Design

Total Participants: 99
Study Start date:
December 01, 2016
Estimated Completion Date:
September 16, 2017

Connect with a study center

  • CHRU de Besancon

    Besancon, 25000
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.